FR0012757854 - Common Stock

We assign a fundamental rating of **5** out of 10 to **SPIE**. **SPIE** was compared to 44 industry peers in the **Commercial Services & Supplies** industry. While **SPIE** is still in line with the averages on profitability rating, there are concerns on its financial health. **SPIE** has a decent growth rate and is not valued too expensively.

In the past year **SPIE** had a positive cash flow from operations.

The **Return On Invested Capital** of **SPIE** (**5.94%**) is comparable to the rest of the industry.

Measured over the past 3 years, the **Average Return On Invested Capital** for **SPIE** is below the industry average of **9.43%**.

The 3 year average ROIC (**5.25%**) for **SPIE** is below the current ROIC(**5.94%**), indicating increased profibility in the last year.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 2.61% | ||

ROE | 12.22% | ||

ROIC | 5.94% |

ROA(3y)2.09%

ROA(5y)1.75%

ROE(3y)10.11%

ROE(5y)8.83%

ROIC(3y)5.25%

ROIC(5y)4.73%

With a **Profit Margin** value of **2.73%**, **SPIE** perfoms like the industry average, outperforming **54.76%** of the companies in the same industry.

In the last couple of years the **Operating Margin** of **SPIE** has grown nicely.

The **Gross Margin** of **SPIE** (**42.82%**) is comparable to the rest of the industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 5.38% | ||

PM (TTM) | 2.73% | ||

GM | 42.82% |

OM growth 3Y13.03%

OM growth 5Y5.09%

PM growth 3Y50.68%

PM growth 5Y14.88%

GM growth 3Y-1.1%

GM growth 5Y1.3%

The debt/assets ratio for **SPIE** has been reduced compared to a year ago.

A Debt/Equity ratio of **1.05** is on the high side and indicates that **SPIE** has dependencies on debt financing.

Looking at the **Debt to Equity ratio**, with a value of **1.05**, **SPIE** is doing worse than **64.29%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.05 | ||

Debt/FCF | 3.82 | ||

Altman-Z | 1.68 |

ROIC/WACC0.94

WACC6.35%

The **Quick ratio** of **SPIE** (**0.91**) is worse than **61.90%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.92 | ||

Quick Ratio | 0.91 |

The **Earnings Per Share** has grown by an impressive **55.46%** over the past year.

The **Earnings Per Share** has been growing by **19.93%** on average over the past years. This is quite good.

The **Revenue** has been growing slightly by **7.54%** in the past year.

The **Revenue** has been growing slightly by **5.44%** on average over the past years.

EPS 1Y (TTM)55.46%

EPS 3Y61.76%

EPS 5Y19.93%

EPS Q2Q%106.29%

Revenue 1Y (TTM)7.54%

Revenue growth 3Y9.43%

Revenue growth 5Y5.44%

Sales Q2Q%-43.18%

The **Earnings Per Share** is expected to grow by **10.64%** on average over the next years. This is quite good.

The **Revenue** is expected to grow by **5.18%** on average over the next years.

EPS Next Y18.62%

EPS Next 2Y13.98%

EPS Next 3Y10.64%

EPS Next 5YN/A

Revenue Next Year12.2%

Revenue Next 2Y8.8%

Revenue Next 3Y7.65%

Revenue Next 5Y5.18%

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

Based on the **Price/Earnings** ratio of **26.11**, the valuation of **SPIE** can be described as expensive.

When comparing the **Price/Earnings** ratio of **SPIE** to the average of the S&P500 Index (**28.24**), we can say **SPIE** is valued inline with the index average.

Based on the **Price/Forward Earnings** ratio of **14.85**, the valuation of **SPIE** can be described as correct.

Compared to the rest of the industry, the **Price/Forward Earnings** ratio of **SPIE** indicates a somewhat cheap valuation: **SPIE** is cheaper than 64.29% of the companies listed in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 26.11 | ||

Fwd PE | 14.85 |

Compared to the rest of the industry, the **Price/Free Cash Flow** ratio of **SPIE** indicates a somewhat cheap valuation: **SPIE** is cheaper than 73.81% of the companies listed in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 9.56 | ||

EV/EBITDA | 9.56 |

The **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

The decent profitability rating of **SPIE** may justify a higher PE ratio.

PEG (NY)1.4

PEG (5Y)1.31

EPS Next 2Y13.98%

EPS Next 3Y10.64%

With a **Yearly Dividend Yield** of **2.30%**, **SPIE** has a reasonable but not impressive dividend return.

Compared to an average industry **Dividend Yield** of **2.92**, **SPIE** pays a bit more dividend than its industry peers.

Compared to an average S&P500 **Dividend Yield** of **2.36**, **SPIE** has a dividend comparable with the average S&P500 company.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.3% |

The dividend of **SPIE** is nicely growing with an annual growth rate of **6.15%**!

Dividend Growth(5Y)6.15%

Div Incr Years3

Div Non Decr Years3

The dividend of **SPIE** is growing, but earnings are growing more, so the dividend growth is sustainable.

DP53.13%

EPS Next 2Y13.98%

EPS Next 3Y10.64%

**SPIE SA**

EPA:SPIE (5/24/2024, 7:00:00 PM)

**37.34**

**+0.5 (+1.36%) **

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCommercial & Professional Services

GICS IndustryCommercial Services & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap6.23B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 2.3% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 26.11 | ||

Fwd PE | 14.85 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)1.4

PEG (5Y)1.31

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 2.61% | ||

ROE | 12.22% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 5.38% | ||

PM (TTM) | 2.73% | ||

GM | 42.82% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.95

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.05 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.92 | ||

Quick Ratio | 0.91 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)55.46%

EPS 3Y61.76%

EPS 5Y

EPS Q2Q%

EPS Next Y18.62%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)7.54%

Revenue growth 3Y9.43%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y